CVS Health CVS announces its next round of earnings this Wednesday, August 7. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement.
Earnings and Revenue
Wall Street analysts see CVS Health reporting earnings of $1.69 per share on sales of $62.65 billion.
CVS Health reported a profit of $1.69 when it published results during the same quarter last year. Sales in that period totaled $46.71 billion. Revenue would be up 34.13% from the same quarter last year. Here's how the company's EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 |
| EPS Estimate | 1.500 | 2.05 | 1.71 | 1.61 |
| EPS Actual | 1.620 | 2.14 | 1.73 | 1.69 |
Stock Performance
Over the last 52-week period, shares are down 16%. Given that these returns are generally negative, long-term shareholders are probably upset going into this earnings release. Over the past 90 days, analysts have generally not modified their estimates for EPS and revenues. The popular rating by analysts on CVS Health stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
CVS Health is scheduled to hold a conference call at 8:00 a.m. ET and it can be accessed here: https://event.on24.com/wcc/r/2017308/CD2A373DDD696235246935AF1A6D9918
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
